• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

环孢菌素-微管蛋白加合物的晶体结构:对紫杉烷结合位点配体激活微管蛋白的影响。

Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands.

机构信息

Structural and Chemical Biology Department. Centro de Investigaciones Biológicas, CSIC, Ramiro de Maeztu 9, 28040 Madrid, Spain.

Laboratory of Biomolecular Research, Division of Biology and Chemistry, Paul Scherrer Institut, 5232 Villigen PSI, Switzerland.

出版信息

Int J Mol Sci. 2019 Mar 20;20(6):1392. doi: 10.3390/ijms20061392.

DOI:10.3390/ijms20061392
PMID:30897704
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6471726/
Abstract

It has been proposed that one of the mechanisms of taxane-site ligand-mediated tubulin activation is modulation of the structure of a switch element (the M-loop) from a disordered form in dimeric tubulin to a folded helical structure in microtubules. Here, we used covalent taxane-site ligands, including cyclostreptin, to gain further insight into this mechanism. The crystal structure of cyclostreptin-bound tubulin reveals covalent binding to βHis229, but no stabilization of the M-loop. The capacity of cyclostreptin to induce microtubule assembly compared to other covalent taxane-site agents demonstrates that the induction of tubulin assembly is not strictly dependent on M-loop stabilization. We further demonstrate that most covalent taxane-site ligands are able to partially overcome drug resistance mediated by βIII-tubulin (βIII) overexpression in HeLa cells, and compare their activities to pironetin, an interfacial covalent inhibitor of tubulin assembly that displays invariant growth inhibition in these cells. Our findings suggest a relationship between a diminished interaction of taxane-site ligands with βIII-tubulin and βIII tubulin-mediated drug resistance. This supports the idea that overexpression of βIII increases microtubule dynamicity by counteracting the enhanced microtubule stability promoted by covalent taxane-site binding ligands.

摘要

有人提出,紫杉烷结合位点配体介导的微管蛋白激活的机制之一是调节开关元件(M 环)的结构,从二聚体微管蛋白中的无序形式转变为微管中的折叠螺旋结构。在这里,我们使用共价紫杉烷结合配体,包括环丝氨酸肽,来进一步深入了解这一机制。环丝氨酸肽结合的微管蛋白的晶体结构揭示了与 βHis229 的共价结合,但没有稳定 M 环。与其他共价紫杉烷结合剂相比,环丝氨酸肽诱导微管组装的能力表明,微管蛋白组装的诱导并不严格依赖于 M 环的稳定。我们进一步证明,大多数共价紫杉烷结合配体能够部分克服 HeLa 细胞中βIII-微管蛋白(βIII)过表达介导的药物耐药性,并将它们的活性与 pironetin 进行比较,pironetin 是一种界面共价抑制剂,对这些细胞中的微管蛋白组装具有不变的生长抑制作用。我们的研究结果表明,紫杉烷结合位点配体与βIII-微管蛋白相互作用减弱与βIII 微管蛋白介导的药物耐药性之间存在关系。这支持了这样一种观点,即βIII 的过表达通过抵消共价紫杉烷结合配体促进的增强的微管稳定性,增加微管的动态性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/a4064e26af34/ijms-20-01392-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/02ba93071431/ijms-20-01392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/e831609f5318/ijms-20-01392-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/5df868fa8caa/ijms-20-01392-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/a5187dabbf05/ijms-20-01392-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/472a3f68e949/ijms-20-01392-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/108aa304d5ee/ijms-20-01392-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/a4064e26af34/ijms-20-01392-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/02ba93071431/ijms-20-01392-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/e831609f5318/ijms-20-01392-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/5df868fa8caa/ijms-20-01392-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/a5187dabbf05/ijms-20-01392-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/472a3f68e949/ijms-20-01392-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/108aa304d5ee/ijms-20-01392-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04ed/6471726/a4064e26af34/ijms-20-01392-sch002.jpg

相似文献

1
Crystal Structure of the Cyclostreptin-Tubulin Adduct: Implications for Tubulin Activation by Taxane-Site Ligands.环孢菌素-微管蛋白加合物的晶体结构:对紫杉烷结合位点配体激活微管蛋白的影响。
Int J Mol Sci. 2019 Mar 20;20(6):1392. doi: 10.3390/ijms20061392.
2
Cyclostreptin and microtubules: is a low-affinity binding site required?环硫肽与微管:是否需要低亲和力结合位点?
Chembiochem. 2010 Jan 4;11(1):101-9. doi: 10.1002/cbic.200900538.
3
Cyclostreptin (FR182877), an antitumor tubulin-polymerizing agent deficient in enhancing tubulin assembly despite its high affinity for the taxoid site.环链菌素(FR182877),一种抗肿瘤微管蛋白聚合剂,尽管其对紫杉烷类位点具有高亲和力,但在增强微管蛋白组装方面存在缺陷。
Biochemistry. 2005 Aug 30;44(34):11525-38. doi: 10.1021/bi050660m.
4
Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.环孢菌素与微管孔及腔内紫杉烷类结合位点共价结合。
Nat Chem Biol. 2007 Feb;3(2):117-25. doi: 10.1038/nchembio853. Epub 2007 Jan 7.
5
Interaction of a cyclostreptin analogue with the microtubule taxoid site: the covalent reaction rapidly follows binding.一种环孢菌素类似物与微管紫杉烷位点的相互作用:共价反应在结合后迅速发生。
J Nat Prod. 2008 Mar;71(3):370-4. doi: 10.1021/np800056m. Epub 2008 Feb 26.
6
Taxanes with high potency inducing tubulin assembly overcome tumoural cell resistances.具有高效诱导微管蛋白组装能力的紫杉烷类药物可克服肿瘤细胞耐药性。
Bioorg Med Chem. 2014 Sep 15;22(18):5078-90. doi: 10.1016/j.bmc.2014.05.048. Epub 2014 Jun 19.
7
Zampanolide, a potent new microtubule-stabilizing agent, covalently reacts with the taxane luminal site in tubulin α,β-heterodimers and microtubules.扎马普隆(Zampanolide)是一种新型强效微管稳定剂,它能与微管蛋白α,β-异二聚体和微管中的紫杉烷腔位点发生共价反应。
Chem Biol. 2012 Jun 22;19(6):686-98. doi: 10.1016/j.chembiol.2012.05.008.
8
Cyclostreptin derivatives specifically target cellular tubulin and further map the paclitaxel site.环丝氨酸肽衍生物特异性靶向细胞微管蛋白,并进一步确定紫杉醇结合位点。
Biochemistry. 2012 Jan 10;51(1):329-41. doi: 10.1021/bi201380p. Epub 2011 Dec 30.
9
βIII-tubulin enhances efficacy of cabazitaxel as compared with docetaxel.与多西他赛相比,βIII微管蛋白可增强卡巴他赛的疗效。
Cancer Chemother Pharmacol. 2017 Jul;80(1):151-164. doi: 10.1007/s00280-017-3345-2. Epub 2017 May 31.
10
Taccalonolide binding to tubulin imparts microtubule stability and potent in vivo activity.塔卡隆内酯与微管蛋白结合赋予微管稳定性和强大的体内活性。
Cancer Res. 2013 Nov 15;73(22):6780-92. doi: 10.1158/0008-5472.CAN-13-1346. Epub 2013 Sep 18.

引用本文的文献

1
Pharmacokinetic and Biodistribution Studies of [F]-Taccalonolide: A Covalent Microtubule Stabilizer with Antitumor Efficacy.[F] - 他卡洛内酯的药代动力学和生物分布研究:一种具有抗肿瘤功效的共价微管稳定剂
ACS Med Chem Lett. 2025 Jul 16;16(8):1569-1574. doi: 10.1021/acsmedchemlett.5c00208. eCollection 2025 Aug 14.
2
Therapy resistance in prostate cancer: mechanism, signaling and reversal strategies.前列腺癌中的治疗耐药性:机制、信号传导及逆转策略
Explor Target Antitumor Ther. 2024;5(5):1110-1134. doi: 10.37349/etat.2024.00266. Epub 2024 Aug 29.
3
Structural insight into the stabilization of microtubules by taxanes.

本文引用的文献

1
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.阿替利珠单抗联合白蛋白紫杉醇治疗晚期三阴性乳腺癌。
N Engl J Med. 2018 Nov 29;379(22):2108-2121. doi: 10.1056/NEJMoa1809615. Epub 2018 Oct 20.
2
Structural Determinants of the Dictyostatin Chemotype for Tubulin Binding Affinity and Antitumor Activity Against Taxane- and Epothilone-Resistant Cancer Cells.针对微管蛋白结合亲和力及对紫杉烷和埃坡霉素耐药癌细胞的抗肿瘤活性,盘基网柄菌素化学型的结构决定因素
ACS Omega. 2016 Dec 31;1(6):1192-1204. doi: 10.1021/acsomega.6b00317. Epub 2016 Dec 13.
3
The absence of class III β-tubulin is predictive of a favorable response to nab-paclitaxel and gemcitabine in patients with unresectable pancreatic ductal adenocarcinoma.
紫杉醇稳定微管的结构见解。
Elife. 2023 Mar 6;12:e84791. doi: 10.7554/eLife.84791.
4
Alternative Approaches to Understand Microtubule Cap Morphology and Function.理解微管帽形态和功能的替代方法。
ACS Omega. 2023 Jan 13;8(4):3540-3550. doi: 10.1021/acsomega.2c06926. eCollection 2023 Jan 31.
5
Taccalonolides: Structure, semi-synthesis, and biological activity.紫杉叶素内酯:结构、半合成及生物活性。
Front Pharmacol. 2022 Aug 11;13:968061. doi: 10.3389/fphar.2022.968061. eCollection 2022.
6
In Vivo Evaluation of (-)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site.体内评估 (-)- 扎那米韦内酯靶向肿瘤部位时表现出强大而持久的抗肿瘤疗效。
Molecules. 2022 Jul 1;27(13):4244. doi: 10.3390/molecules27134244.
7
Molecular Evolution of Tubulins in Diatoms.硅藻微管蛋白的分子进化。
Int J Mol Sci. 2022 Jan 6;23(2):618. doi: 10.3390/ijms23020618.
8
CLIP-170S is a microtubule +TIP variant that confers resistance to taxanes by impairing drug-target engagement.CLIP-170S 是一种微管 +TIP 变体,通过损害药物靶点结合来赋予紫杉醇类药物抗性。
Dev Cell. 2021 Dec 6;56(23):3264-3275.e7. doi: 10.1016/j.devcel.2021.09.023. Epub 2021 Oct 20.
9
Efficacy of a Covalent Microtubule Stabilizer in Taxane-Resistant Ovarian Cancer Models.共价微管稳定剂在紫杉烷耐药卵巢癌模型中的疗效。
Molecules. 2021 Jul 3;26(13):4077. doi: 10.3390/molecules26134077.
10
Taccalonolide C-6 Analogues, Including Paclitaxel Hybrids, Demonstrate Improved Microtubule Polymerizing Activities.Taccalonolide C-6 类似物,包括紫杉醇杂合体,显示出增强的微管聚合活性。
J Nat Prod. 2021 Jun 25;84(6):1799-1805. doi: 10.1021/acs.jnatprod.1c00211. Epub 2021 Jun 10.
III 类β-微管蛋白缺失可预测不可切除的胰腺导管腺癌患者对 nab-紫杉醇和吉西他滨的治疗反应良好。
Hum Pathol. 2018 Apr;74:92-98. doi: 10.1016/j.humpath.2018.01.009. Epub 2018 Jan 12.
4
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study.转移性去势抵抗性前列腺癌患者在恩扎卢胺治疗进展后应用双氢睾酮治疗:一项开放标签、多队列 2 期临床研究。
Lancet Oncol. 2018 Jan;19(1):76-86. doi: 10.1016/S1470-2045(17)30906-3. Epub 2017 Dec 14.
5
Zampanolide Binding to Tubulin Indicates Cross-Talk of Taxane Site with Colchicine and Nucleotide Sites.扎那米韦结合微管蛋白表明紫杉醇结合位点与秋水仙碱和核苷酸结合位点的串扰。
J Nat Prod. 2018 Mar 23;81(3):494-505. doi: 10.1021/acs.jnatprod.7b00704. Epub 2017 Oct 12.
6
Modification of C-seco taxoids through ring tethering and substituent replacement leading to effective agents against tumor drug resistance mediated by βIII-Tubulin and P-glycoprotein (P-gp) overexpressions.通过环连接和取代基替换对 C-断紫杉烷进行修饰,得到有效抑制βIII-微管蛋白和 P 糖蛋白(P-gp)过表达介导的肿瘤耐药的药物。
Eur J Med Chem. 2017 Sep 8;137:488-503. doi: 10.1016/j.ejmech.2017.06.001. Epub 2017 Jun 3.
7
Mechanism of microtubule stabilization by taccalonolide AJ.微管稳定化的机制由土瓜酮 AJ 实现。
Nat Commun. 2017 Jun 6;8:15787. doi: 10.1038/ncomms15787.
8
Triazolopyrimidines Are Microtubule-Stabilizing Agents that Bind the Vinca Inhibitor Site of Tubulin.三唑并嘧啶类化合物是微管稳定剂,可结合微管蛋白的长春碱抑制剂结合位点。
Cell Chem Biol. 2017 Jun 22;24(6):737-750.e6. doi: 10.1016/j.chembiol.2017.05.016. Epub 2017 Jun 1.
9
Zampanolide, a Microtubule-Stabilizing Agent, Is Active in Resistant Cancer Cells and Inhibits Cell Migration.扎马普诺利德,一种微管稳定剂,在耐药癌细胞中具有活性并抑制细胞迁移。
Int J Mol Sci. 2017 May 3;18(5):971. doi: 10.3390/ijms18050971.
10
Structural Basis of Microtubule Stabilization by Discodermolide.Discodermolide对微管稳定作用的结构基础
Chembiochem. 2017 May 18;18(10):905-909. doi: 10.1002/cbic.201600696. Epub 2017 Mar 27.